Winslow Capital Management
ZBH icon

Winslow Capital Management’s Zimmer Biomet ZBH Stock Holding History

Winslow Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-53
Closed -$5K – 102
2016
Q4 		$5K Sell
53
-2,814,774
-100% -$302M ﹤0.01% 79
2016
Q3 		$355M Buy
2,814,827
+162,290
+6% +$20.1M 1.48% 23
2016
Q2 		$310M Buy
+2,652,537
New +$300M 1.27% 35

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Capital Management's ZBH Position: Q1 2017 in Review

Winslow Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 53 shares — an estimated $5K sold.

Winslow Capital Management first reported a position in ZBH in Q2 2016 and held it in 3 quarters. The position peaked at $355M in Q3 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • Winslow Capital Management reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
  • Winslow Capital Management sold 53 Zimmer Biomet shares in Q1 2017, an estimated $5K.
  • Winslow Capital Management first reported a position in Zimmer Biomet in Q2 2016 and held it in 3 quarters.
  • Winslow Capital Management's Zimmer Biomet position peaked at $355M in Q3 2016.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Winslow Capital Management's 13F filing for Q1 2017, filed 12 May 2017.